EPFL .NeuroRestore team expands enrollment criteria for spinal stimulation study
The team announced relaxed enrollment criteria to include patients with longer injury duration, testing therapy applicability across different disease stages.
The team announced relaxed enrollment criteria to include patients with longer injury duration, testing therapy applicability across different disease stages.
The retrospective analysis reviews functional longevity across decades of Utah array implants, providing a historical benchmark for next-generation chronic device design.
The study proposes a neuromorphic on-chip decoding architecture, reducing power consumption by an order of magnitude versus conventional digital signal processing.
The closed-loop protocol dynamically adjusted stimulation based on real-time neural signals, yielding significantly greater symptom improvement versus open-loop controls.
The study reports methods for evoking finer-grained phosphene patterns via high-density surface arrays, offering a path toward higher-resolution visual information for blind patients.
The system uses external RF power delivery for fully wireless recording, removing the mobility constraints of wired connections; validated in animal models.
The study compared glial scarring around flexible versus rigid electrodes, finding significantly milder tissue response in the flexible group.
Multiple chronic spinal cord injury participants achieved independent overground walking with stimulation assistance, with some retaining partial gains even after the device was turned off.
The study integrates large language models into post-decoding processing, further reducing word error rate toward conversational usability.
Researchers tracked signal quality of high-density arrays implanted over two years, finding roughly 70% of channels still yielding usable signal.
MIIT and partner agencies issue guidance on BCI industry development
The guidance sets a 2027 target for cultivating internationally competitive BCI enterprises, with specific measures on standards and clinical access.
Neuracle epilepsy monitoring electrode multicenter study passes halfway enrollment
The study evaluates the precision of a new cortical electrode in localizing epileptogenic foci; enrollment has passed the halfway mark, with completion expected within the year.
BrainCo launches real-world evidence study for rehabilitation training system
The study targets existing users of the already-marketed consumer rehabilitation product, collecting long-term usage data to support future indication expansion.
The trial evaluates the companys neural interface system in assisting paralyzed patients with daily tasks; the new site is expected to accelerate enrollment.
StairMed motor function restoration study completes interim summary
The team disclosed interim data showing participants completing simple robotic arm tasks via the device, with plans to expand the sample size.
NeuroXess investigator-initiated speech decoding study progress update
The investigator-initiated study, run jointly with domestic hospitals, has completed several implants using flexible cortical electrodes for real-time text decoding.
Following the 30-day implantation clearance, the company announced the launch of a pivotal-stage study targeting motor function restoration.
The trial evaluates BCI combined with spinal cord stimulation for upper-limb recovery in spinal cord injury patients; the first procedure was completed in the Netherlands.
The report discloses electrode channel attrition among early participants; most channels remained stable while a minority showed gradual signal degradation.
Data showed no device-related serious adverse events across participants, with functional usage metrics improving further from the early feasibility stage.
The preprint reports a new record in simultaneous recording scale in rodent models, with probe fabrication supported by imec.
The Breakthrough Device designation is expected to accelerate FDA review of the next-generation recording array intended for multiple indications.
Neuracle closes new funding round, deepens research-tooling business
The company, focused on neural electrophysiology recording equipment, will use the funds to develop high-channel acquisition systems and expand capacity.
StairMed reports progress in speech decoding research
The team disclosed updated decoding accuracy figures, with the participant achieving continuous sentence output — reportedly the best publicly disclosed result on this technical route domestically.
BrainCo receives approval for consumer neurofeedback product
The product targets attention training and rehabilitation support, among the first domestically approved consumer-grade BCI products.
ARC-EX is a non-invasive spinal cord stimulation device aimed at restoring hand function in spinal cord injury patients, now cleared for EU commercial sale.
NeuroXess closes new funding round to scale flexible electrode production
The round was co-led by industrial and state-backed investors, funding a production line expansion and continued clinical work on speech decoding.
The round will fund Synchrons pivotal COMMAND trial and commercialization efforts, among the largest single rounds in the BCI sector to date.
Neuralink disclosed expanded enrollment in its PRIME early feasibility study, with early participants sustaining over a year of stable device operation.
The device was previously cleared only for intraoperative use up to 30 minutes. Extending to 30 days opens the door to longer-duration clinical studies.